228 related articles for article (PubMed ID: 1611648)
1. Loracarbef (LY163892) versus amoxicillin/clavulanate in bronchopneumonia and lobar pneumonia.
Hyslop DL; Jacobson K; Guerra FJ
Clin Ther; 1992; 14(2):254-67. PubMed ID: 1611648
[TBL] [Abstract][Full Text] [Related]
2. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute purulent bacterial bronchitis.
Dere WH; Farlow D; Therasse DG; Jacobson KD; Guerra FJ
Clin Ther; 1992; 14(2):166-77. PubMed ID: 1611641
[TBL] [Abstract][Full Text] [Related]
3. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
Zeckel ML; Jacobson KD; Guerra FJ; Therasse DG; Farlow D
Clin Ther; 1992; 14(2):214-29. PubMed ID: 1611645
[TBL] [Abstract][Full Text] [Related]
4. Loracarbef (LY163892) versus amoxicillin-clavulanate in the treatment of bacterial acute otitis media with effusion.
Foshee WS
J Pediatr; 1992 Jun; 120(6):980-6. PubMed ID: 1593361
[TBL] [Abstract][Full Text] [Related]
5. Comparison of loracarbef (LY163892) versus amoxicillin in the treatment of bronchopneumonia and lobar pneumonia.
Müller O; Wettich K
Infection; 1992; 20(3):176-82. PubMed ID: 1463527
[TBL] [Abstract][Full Text] [Related]
6. Loracarbef (LY 163892) vs amoxicillin/clavulanate in bacterial maxillary sinusitis.
Sydnor TA; Scheld WM; Gwaltney J; Nielsen RW; Huck W; Therasse DG
Ear Nose Throat J; 1992 May; 71(5):225-32. PubMed ID: 1505371
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of loracarbef in the treatment of pneumonia.
Hyslop DL
Am J Med; 1992 Jun; 92(6A):65S-69S. PubMed ID: 1621747
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of clarithromycin vs. amoxicillin/clavulanate in the treatment of acute maxillary sinusitis.
Dubois J; Saint-Pierre C; Tremblay C
Ear Nose Throat J; 1993 Dec; 72(12):804-10. PubMed ID: 8313865
[TBL] [Abstract][Full Text] [Related]
9. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
Dere WH; Farlow D; Therasse DG; Ruoff GE
Clin Ther; 1992; 14(1):41-53. PubMed ID: 1576625
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections.
Tassler H
Am J Med; 1993 Mar; 94(3A):159S-165S. PubMed ID: 8452174
[TBL] [Abstract][Full Text] [Related]
11. Open trial of oral fleroxacin versus amoxicillin/clavulanate in the treatment of infections of skin and soft tissue.
Powers RD
Am J Med; 1993 Mar; 94(3A):155S-158S. PubMed ID: 8452173
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of loracarbef and amoxicillin-clavulanate for acute otitis media.
Gan VN; Kusmiesz H; Shelton S; Nelson JD
Antimicrob Agents Chemother; 1991 May; 35(5):967-71. PubMed ID: 1854178
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.
Henry D; Ruoff GE; Rhudy J; Puopolo A; Drehobl M; Schoenberger J; Giguere G; Collins JJ
Antimicrob Agents Chemother; 1995 Nov; 39(11):2528-34. PubMed ID: 8585739
[TBL] [Abstract][Full Text] [Related]
14. Twice-daily antibiotics in the treatment of acute otitis media: trimethoprim-sulfamethoxazole versus amoxicillin-clavulanate.
Feldman W; Sutcliffe T; Dulberg C
CMAJ; 1990 Jan; 142(2):115-8. PubMed ID: 2403833
[TBL] [Abstract][Full Text] [Related]
15. Loracarbef (LY163892) in the treatment of acute exacerbations of chronic bronchitis: results of U.S. and European comparative clinical trials.
Zeckel ML
Am J Med; 1992 Jun; 92(6A):58S-64S. PubMed ID: 1621746
[TBL] [Abstract][Full Text] [Related]
16. Review of the experience with cefprozil for the treatment of lower respiratory tract infections.
Pelletier LL
Clin Infect Dis; 1992 Jun; 14 Suppl 2():S238-43; discussion S244-5. PubMed ID: 1617044
[TBL] [Abstract][Full Text] [Related]
17. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis.
Camacho AE; Cobo R; Otte J; Spector SL; Lerner CJ; Garrison NA; Miniti A; Mydlow PK; Giguere GC; Collins JJ
Am J Med; 1992 Sep; 93(3):271-6. PubMed ID: 1524078
[TBL] [Abstract][Full Text] [Related]
18. Ofloxacin in the treatment of lower respiratory tract infections: report of a prospective, comparative trial.
Khajotia RR; Vetter N; Harazin H
Clin Ther; 1991; 13(4):460-6. PubMed ID: 1933997
[TBL] [Abstract][Full Text] [Related]
19. Comparison of oral fleroxacin with oral amoxicillin/clavulanate for treatment of skin and soft tissue infections.
Smith JW; Nichols RL
Am J Med; 1993 Mar; 94(3A):150S-154S. PubMed ID: 8452172
[TBL] [Abstract][Full Text] [Related]
20. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with secondary bacterial infections of acute bronchitis.
Henry D; Ruoff GE; Rhudy J; Puopolo A; Drehobl M; Schoenberger J; Giguere G; Collins JJ
Clin Ther; 1995; 17(5):861-74. PubMed ID: 8595638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
